{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Array Biopharma", "item": "https://www.patentleaderboard.com/2021/company/array-biopharma"}, {"@type": "ListItem", "position": 4, "name": "Laurence E. Burgess", "item": "https://www.patentleaderboard.com/2021/inventor/fl:la_ln:burgess-1"}]}

Home › 2021 › Array Biopharma › Laurence E. Burgess

Laurence E. Burgess — 1 Patent in 2021

ABArray Biopharma: 1 patents #24 of 57Top 45%

Bristol-Myers Squibb: 1 patents #182 of 545Top 35%

Boulder, CO: #250 of 683 inventorsTop 40%

Colorado: #1,686 of 5,235 inventorsTop 35%

Overall (2021): #365,640 of 548,734Top 70%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
11028093	4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors	Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more	2021-06-08

Laurence E. Burgess — 1 Patent in 2021

Issued Patents 2021

Patent Widget